Eugia Pharma's Generic Erlotinib Hydrochloride Receives Approval in US
Zydus Pharms`s Generic Erlotinib Hydrochloride Receives Approval in US
Apotex`s Generic Glycopyrrolate Receives Approval in US
Natco Pharma’s Generic Erlotinib Hydrochloride Receives Approval In US
Sun Pharm`s generic Generic Erlotinib Hydrochloride Receives Approval In US
Shilpa Medicare`s GenericErlotinib Hydrochloride Receives Approval in US
Global pharmaceutical company Mylan N.V. (NASDAQ: MYL) today announced the U.S. launch of Erlotinib Hydrochloride Tablets, 25 mg, 100 mg and 150 mg, a generic version of Genentech's Tarceva®. Mylan Pharmaceuticals received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for this product.
Tarceva¨ (erlotinib hydrochloride): OSI Pharmaceuticals, LLC et al v. Shilpa Medicare Limited
Brazil has cut the import duty on three drugs that are used for kidney transplants and for treating lung and kidney cancer.nnThe reductions were made through CAMEX Resolution No. 120/2015, which was published in the Official Gazette on December 18, 2015.nnUnder the resolution, the import duty on basiliximab, a drug used in kidney transplants, was reduced from two percent to zero percent.
A division bench of the Delhi High Court sided with Roche against Indian firm Cipla, upholding the Swiss drug maker's patent claims on key lung cancer drug erlotinib hydrochloride, branded Tarceva. The ruling is the second in a month to have upheld patent rights of an overseas drug company and sets akey precedent with regard to intellectual property, experts said.